Trials / Unknown
UnknownNCT05792527
L-carnitine in Modulating Pain and Inflammation in Rheumatoid Arthritis
The Use of L-carnitine in Modulating Pain and Inflammation in Rheumatoid Arthritis Patients
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study aims at evaluating the possible efficacy and safety of L-carnitine in rheumatoid arthritis via targeting Jak/STAT pathway and TGF-β1
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L-carnitine | One 500 mg tablet twice daily after meals |
Timeline
- Start date
- 2023-03-05
- Primary completion
- 2025-03-05
- Completion
- 2026-03-05
- First posted
- 2023-03-31
- Last updated
- 2023-03-31
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05792527. Inclusion in this directory is not an endorsement.